← Evidence map

ArticleCritical care (London, England)2006

Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death.

Mark D Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2006

this papercites it

Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death. | OpenQuestion